glp 1 agonist dpp 4 inhibitor Inhibition of DPP-4. Food consumption boosts the release of GLP-1 and Mechanism of action for GIP,
Description
Therefore, the development of novel, safer, and more effective therapies for the clinical management of women with PCOS and their metabolic complications remains an unmet medical need

Phase 3 trial of semaglutide in metabolic dysfunction-associated steatohepatitis
2019;139:e56-528

The rapid evolution of obesity therapeutics coincides with a broader global health crisis

Treatment with liraglutide, a glucagon-like peptide-1 analogue, improves effectively the skin lesions of psoriasis patients with type 2 diabetes: A prospective cohort study
